To assess whether moderate-to-severe CKD is a treatment modifier for benefit or harm in patients randomly allocated to 24-month versus 6-month DAPT.

Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial / Gargiulo, G., Santucci, A., Piccolo, R., Franzone, A., Ariotti, S., Baldo, A., Esposito, G., Moschovitis, A., Windecker, S., Valgimigli, M.. - In: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. - ISSN 1522-1946. - (2017). [10.1002/ccd.26921]

Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial

GARGIULO, GIUSEPPE;PICCOLO, RAFFAELE;FRANZONE, ANNA;ESPOSITO, GIOVANNI;
2017

Abstract

To assess whether moderate-to-severe CKD is a treatment modifier for benefit or harm in patients randomly allocated to 24-month versus 6-month DAPT.
2017
Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial / Gargiulo, G., Santucci, A., Piccolo, R., Franzone, A., Ariotti, S., Baldo, A., Esposito, G., Moschovitis, A., Windecker, S., Valgimigli, M.. - In: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. - ISSN 1522-1946. - (2017). [10.1002/ccd.26921]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/673269
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 23
social impact